Results 1 to 10 of about 426,193 (215)

Towards antibody-based immunotherapy development for platinum-resistant high-grade serous ovarian cancer. [PDF]

open access: yesSci Rep
Epithelial ovarian cancer is the sixth most common malignant neoplasm in women and the leading cause of death from gynecological malignancies in the Western World.
Giedraityte Z   +4 more
europepmc   +2 more sources

Polycythemia vera and stiff-person syndrome: a case report. [PDF]

open access: yesBMC Neurol
Background Polycythemia vera (PV) is a myeloproliferative neoplasm, characterized by trilineage hypercellularity, which increases the risk of thrombosis.
Mu H   +8 more
europepmc   +2 more sources

Carcinoid of the gallbladder in two dogs [PDF]

open access: yesCiência Rural, 2020
: A carcinoid is a rare neoplasm derived from neuroendocrine cells that may arise in the hepatobiliary system. This report described two cases of carcinoid of the gallbladder in dogs, with emphasis on the clinical, pathological and immunohistochemical ...
Fernando Froner Argenta   +7 more
doaj   +1 more source

Arthritis as a presentation of paraneoplastic syndrome: A case report

open access: yesLiječnički vjesnik, 2023
Paraneoplastic syndrome includes symptoms that occur far from the primary tumor, and despite unclear pathogenesis, these conditions are thought to be caused by substances secreted by the neoplasm or by the effect of antibodies directed at the tumor ...
Matea Lukić   +3 more
doaj   +1 more source

Antibody targeting of mutant calreticulin in myeloproliferative neoplasms

open access: yesJournal of Cellular and Molecular Medicine, 2023
AbstractMutations in calreticulin are one of the key disease‐initiating mutations in myeloproliferative neoplasms (MPN). In MPN, mutant calreticulin translates with a novel C‐terminus that leads to aberrant binding to the extracellular domain of the thrombopoietin receptor, MPL.
Frederike Kramer, Ann Mullally
openaire   +2 more sources

IgE Plasma Cell Leukemia Harboring t(11;14) and 1q Amplification

open access: yesCase Reports in Hematology, 2023
IgE plasma cell neoplasm is the rarest subtype of plasma cell neoplasms and is known for its poor prognosis and high incidence of t(11;14). However, t(11;14) has been classified as a standard-risk rather than high-risk cytogenetic abnormality in multiple
Wataru Nakahara   +10 more
doaj   +1 more source

Mixed neuroendocrine–non‐neuroendocrine neoplasm associated with autoimmune gastritis

open access: yesClinical Case Reports, 2022
A 60‐year‐old woman presented with a protruding tumor at the anterior wall of the middle gastric body, and she was positive for anti‐parietal cells antibodies with elevated serum gastrin level.
Naoko Mori   +9 more
doaj   +1 more source

Myofibroma of the gingiva – A rare case of diagnostic predicament

open access: yesJournal of International Clinical Dental Research Organization, 2023
Myofibroma is a very uncommon benign soft-tissue neoplasm occurring very rarely in the oral cavity with rare occurrence seen in the gingiva. Being a rare entity, the knowledge about microscopic features is important in its diagnosis and treatment ...
Arunima Sarma   +5 more
doaj   +1 more source

Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms

open access: yesOpen Life Sciences, 2023
Abstract The morbidity and mortality of BCR-ABL-negative myeloproliferative neoplasia (MPN) patients is highly dependent on thrombosis that may be affected by antiphospholipid antibodies (aPLA) and lupus anticoagulant. Our aim was to evaluate the association of the aPLA together with platelet receptor glycoprotein (GP) Ia/IIa c.807C>T
Dambrauskienė Rūta   +8 more
openaire   +3 more sources

Monoclonal antibodies in cervical malignancy-related HPV

open access: yesFrontiers in Oncology, 2022
Despite many efforts to treat HPV infection, cervical cancer survival is still poor for several reasons, including resistance to chemotherapy and relapse. Numerous treatments such as surgery, radiation therapy, immune cell-based therapies, siRNA combined
Parisa Shiri Aghbash   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy